Task: Answer the multiple choice question.
Query: Which drug exhibits a 0.195\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. Cc1ccc2nc(C3CCCN(C(=S)Nc4ccccc4C)C3)[nH]c2c1
b. Cc1cccc(-c2noc(-c3ccc4c(c3)OCO4)n2)c1
c. C/C(=N\NC(=O)c1ccccc1)c1ccc(NC(=O)c2cccs2)cc1
Answer: a. Cc1ccc2nc(C3CCCN(C(=S)Nc4ccccc4C)C3)[nH]c2c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
3-(6-methyl-1H-benzimidazol-2-yl)-N-(2-methylphenyl)piperidine-1-carbothioamide